Breast Cancer Research Centre

Nedlands 6009

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, HER2 Positive Breast Cancer

Studies at this site

• Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) — Recruiting now
• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed